Language isolate

Pear Therapeutics Announces New 12-Month Analysis Showing Reduction in Healthcare Resource Utilization and Associated Costs in Patients Treated with reSET-O®

Retrieved on: 
Tuesday, June 14, 2022
Research, General Health, Pharmaceutical, Telemedicine, Virtual Medicine, Mental Health, Health Technology, Clinical Trials, Science, Biotechnology, FDA, Other Science, Health, Opioid use disorder, ClinicoEconomics and Outcomes Research, Adult, BA, Journal, OUD, Doctor of Philosophy, MBA, IP, DOI, Cognitive behavioral therapy, Policy, Pharmacoeconomics, Forward-looking statement, Treatment, Insomnia, Buprenorphine, Therapy, Health, Digital, Language isolate, FDA, Risk, Manuscript, Patient, Current Medical Research and Opinion, Journal of Medical Economics, COVID-19, Suicidal ideation, Safety, PDT, Incidence, Policy by press release, SEC, Postgraduate Medicine, MD, PEAR, Reading, Population, ICU, Medicaid, Terminology, Comparison, Smartphone, Hospital Practice, Pharmaceutical industry, Hospital, Health insurance, Medical device, Nasdaq, Pear

The results of this analysis demonstrated that patients who were treated with reSET-O showed lower incidence of inpatient stays and emergency department visits, compared to control patients.

Key Points: 
  • The results of this analysis demonstrated that patients who were treated with reSET-O showed lower incidence of inpatient stays and emergency department visits, compared to control patients.
  • The study used claims data to evaluate 901 adult patients who were prescribed and treated with reSET-O compared to 978 controls.
  • Reduced healthcare resource utilization in patients with opioid use disorder in the 12 months after initiation of a prescription digital therapeutic.
  • Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder.

Voltron Data Announces Speaker Line-Up for The Data Thread, a Conference Showcasing the Latest Innovation Around Apache Arrow and Data Analytics

Retrieved on: 
Thursday, June 9, 2022
Arrow, CTO, Language isolate, RStudio, Meta, CEO, Apache, University at Buffalo, MinIO, Princeton University, Buffalo, University, Massachusetts Institute of Technology, GLOBE, University of Liverpool, WorldQuant, SAN, Carnegie Mellon University, Data science, Apache Arrow, Microsoft, University of California, Mobile phone, Anaconda

Arrow is a multi-language toolbox for accelerated data interchange and in-memory computing.

Key Points: 
  • Arrow is a multi-language toolbox for accelerated data interchange and in-memory computing.
  • It has become the de facto standard for seamless interoperability between computing engines, modern computing hardware and programming languages.
  • The Data Thread will feature an opening keynote by Apache Arrow co-creators Wes McKinney, co-founder and CTO of Voltron Data, and Jacques Nadeau, co-founder and CEO of Sundeck.
  • To register for The Data Thread or for more information on the conference, go to: https://thedatathread.com
    Voltron Data believes in building more bridges across the data science and analytics industry to accelerate the efficient development of data tools.

Governments of Canada and New Brunswick invest more than $27.8 million in Université de Moncton

Retrieved on: 
Friday, June 3, 2022
Pavillon, Language, Advertising, Atlantic Canada Opportunities Agency, Research, Universitate metro station, Partnership, Government, Language isolate, Atlantic Canada, Investment, Student, Laboratory, Tertiary, Shippagan, Official Languages Act (Canada), English, Learning, Investor, Government of New Brunswick, Federation, Education, Local, Government of Canada Building, Oil, Tutoring, Civil engineering, Medicine, Labour, NB

Substantial support for Acadian and Francophone communities: The governments of Canada and New Brunswick announce significant funding for the Universit de Moncton.

Key Points: 
  • Substantial support for Acadian and Francophone communities: The governments of Canada and New Brunswick announce significant funding for the Universit de Moncton.
  • MONCTON, NB, June 3, 2022 /CNW Telbec/ - The Government of Canada is committed to ensuring that all Canadians can learn in the official language of their choice.
  • Today, the Honourable Ginette Petitpas Taylor, Minister of Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency, announced more than $27.8million in financial support for three projects at the Universit de Moncton.
  • The Universit de Moncton is a post-secondary institution with three exclusively French-language campuses in Moncton, Edmundston and Shippagan.

Governments of Canada and New Brunswick provide more than $6.6 million to Collège communautaire du Nouveau-Brunswick

Retrieved on: 
Friday, May 27, 2022
Employment, English, Language isolate, CCNB, Population, Parliament, News, Investment, Goal, NB, Government, Atlantic Canada, Social skills, Official Languages Act (Canada), Federation, Edmundston, Student, Local, Atlantic Canada Opportunities Agency, Technology, Municipal government in Canada, Government of New Brunswick, Animal, Management, Oil

Today, the Honourable Ginette Petitpas Taylor, Minister of Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency, announced support of more than $6.6 million for three projects of the Collge communautaire du Nouveau-Brunswick (CCNB).

Key Points: 
  • Today, the Honourable Ginette Petitpas Taylor, Minister of Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency, announced support of more than $6.6 million for three projects of the Collge communautaire du Nouveau-Brunswick (CCNB).
  • This project will be supported by funding of $2 million from the federal government and $1.2 million from the provincial government.
  • The CCNB thanks the governments of Canada and New Brunswick for their confidence in us."
  • The Collge communautaire du Nouveau-Brunswick has been a fully autonomous Francophone college corporation since May 30, 2010.

The governments of Canada and British Columbia invest more than $4.7 million in French-language postsecondary education in British Columbia

Retrieved on: 
Wednesday, May 25, 2022
English, Language isolate, University, UBC, University of Victoria, Language, Atlantic Canada, Official Languages Act (Canada), University of British Columbia Library, Partnership, University of British Columbia, Center, Student, Action plan, Atlantic Canada Opportunities Agency, Legislative assembly, Faculty, School, Times Higher Education World University Rankings, Legislative Assembly of Ontario, Indigenous self-government in Canada, Government, Online gambling, Forestry, Tutoring, Medicine, Management, BC, Education

The governments of Canada and British Columbia announce a major investment for French-language postsecondary education in British Columbia.

Key Points: 
  • The governments of Canada and British Columbia announce a major investment for French-language postsecondary education in British Columbia.
  • VANCOUVER, BC, May 25, 2022 /CNW/ - Education is key to ensuring the equality of our two official languages in the education system, from early childhood to postsecondary.
  • Today, theHonourable Ginette PetitpasTaylor, Minister of Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency, announced more than $4.7million in funding to support French-language postsecondary education in British Columbia.
  • The University of British Columbia is ranked 34th in Times Higher Education World University Rankings and one of three Canadian universities in the top 50.

Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting

Retrieved on: 
Tuesday, May 24, 2022
Technology, Other Technology, Software, Biotechnology, Health, Pharmaceutical, General Health, Other Science, Science, Smartphone, Digital, MBA, Risk, Population, Health equity, Annual general meeting, Mental health, PEAR, Suicidal ideation, American, Patient, Poster, American Psychiatric Association, Therapy, PDT, COVID-19, APA, FDA, Press release, Opioid use disorder, Forward-looking statement, Florida statistical areas, Buprenorphine, Terminology, Reading, Language isolate, Metro, OUD, Cognitive behavioral therapy, SEC, Database, Insomnia, MD, Pharmaceutical industry, Medical device, Risk management, Pear, Nasdaq

Thats why its also important to evaluate associations between geographic regions in the US and levels of engagement with treatment like prescription digital therapeutics, said Yuri Maricich, MD, MBA, Chief Medical Officer, Pear Therapeutics.

Key Points: 
  • Thats why its also important to evaluate associations between geographic regions in the US and levels of engagement with treatment like prescription digital therapeutics, said Yuri Maricich, MD, MBA, Chief Medical Officer, Pear Therapeutics.
  • These results suggest reSET-O may enable access to behavioral treatments for OUD across geographic areas, which can help address health equity for those seeking recovery.
  • Patients with opioid use disorder experience mental health disease and co-morbid medical problems at higher rates than the general population.
  • Advancing Health Equity: Evidence That a Prescription Digital Therapeutic for Opioid Use Disorder Enables Healthcare Access Across Geographic Regions.

Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative

Retrieved on: 
Thursday, May 12, 2022
Data Management, Other Health, Technology, Pharmaceutical, Mental Health, General Health, Medical Devices, Other Technology, Science, Telecommunications, Biotechnology, Software, Other Science, Health, Research, Smartphone, COVID-19, Risk, Population, PEAR, Suicidal ideation, Patient, Therapy, Privacy, PDT, FDA, Opioid, Press release, Telehealth, Opioid use disorder, Buprenorphine, Program, Terminology, Communication, Reading, Language isolate, OUD, Cognitive behavioral therapy, SEC, Insomnia, United States drug overdose death rates and totals over time, Pharmaceutical industry, Medical device, Risk management, Pear, Nasdaq

QuickMD works to offer treatment options to our patients that provide security and privacy in a telemedicine environment, all from the privacy of a patients home.

Key Points: 
  • QuickMD works to offer treatment options to our patients that provide security and privacy in a telemedicine environment, all from the privacy of a patients home.
  • Pear is pleased to work with telehealth providers in providing innovative, FDA-authorized treatments that enable round-the-clock access to assist eligible patients in their recovery journey during these difficult times, said Julia Strandberg, Chief Commercial Officer at Pear Therapeutics.
  • Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs).
  • For example, statements regarding round-the-clock access to, and the continued availability of, the QuickMD telehealth platform are forward-looking statements.

BestRx Pharmacy Management Software is now integrated with ScriptAbility

Retrieved on: 
Monday, May 9, 2022
Hospital, RFID, Health, OAK, Death, Patient, Partnership, Medicine, CSSL, ScripTalk, Workflow, Visual impairment, Mistake, Language isolate, Pharmacy, Technology, Growth, Severe cognitive impairment, Risk, Typesetting, Pharmaceutical industry, Health insurance

OAK BROOK, Ill., May 9, 2022 /PRNewswire-PRWeb/ -- BestRx is proud to announce their Pharmacy Management Software is now integrated with ScriptAbility. ScriptAbility is part of En-Vision America, Inc., a company that provides high-tech products, including a variety of accessible pharmacy labels. By forming this partnership, BestRx and ScriptAbility are helping independent pharmacies better care for patients with visual and language barriers.

Key Points: 
  • BestRx is proud to announce their Pharmacy Management Software is now integrated with ScriptAbility.
  • OAK BROOK, Ill., May 9, 2022 /PRNewswire-PRWeb/ -- BestRx is proud to announce their Pharmacy Management Software is now integrated with ScriptAbility.
  • ScriptAbility is part of En-Vision America, Inc., a company that provides high-tech products, including a variety of accessible pharmacy labels.
  • Through the new integration, BestRx pharmacies can quickly produce these labels because ScriptAbility's easy-to-use application can be accessed directly from their pharmacy management software.

The Government of Canada provides nearly $1.9 million to the University of Sudbury

Retrieved on: 
Friday, April 29, 2022
Indigenous self-government in Canada, Parliament, University of Sudbury, Parliamentary system, Language isolate, English, Official Languages Act (Canada), Government, Investment, Mid-North Monitor, Student, Atlantic Canada, History, Goal, Dream, Heart, News, Language, Board, University, Population, Second, Connecticut Board of Regents for Higher Education, Atlantic Canada Opportunities Agency, TheFunded, Regent, Film, Animal, Medicine, Renewable energy, Greater Sudbury, Franco-Ontarian

Today, theHonourable Ginette PetitpasTaylor, Minister of Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency, announced nearly $1.9million in funding for the University of Sudbury.

Key Points: 
  • Today, theHonourable Ginette PetitpasTaylor, Minister of Official Languages and Minister responsible for the Atlantic Canada Opportunities Agency, announced nearly $1.9million in funding for the University of Sudbury.
  • The Minister was accompanied by MarcG.Serr, Parliamentary Secretary to the Minister of Official Languages and Member of Parliament for Nickel Belt, and VivianeLapointe, Member of Parliament for Sudbury.
  • TheUniversity of Sudbury wishes to return to its Francophone roots as an autonomous French-language university based on the principle of governance "by and for" the Francophone community.
  • Today's announcement by the Government of Canada will allow the university to achieve its goals.

Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit

Retrieved on: 
Monday, April 18, 2022
Biotechnology, Health, Pharmaceutical, Technology, Software, Patient, Buprenorphine, CEO, MCPHS University, Language isolate, Suicidal ideation, Drive, Health equity, Population, COVID-19, MBA, Policy by press release, Software, MD, Clinical pharmacy, Pharmacist, OUD, Associate, GMP, Organization, Session, Opioid use disorder, SUD, Smartphone, Therapy, Doctor of Pharmacy, Environment, Insomnia, Reading, Cognitive behavioral therapy, PEAR, Safety, Digital, Substance use disorder, Reset, Population Health Management, Ballroom dance, FDA, Chief Medical Officer (Ireland), Risk, Pear, Medicaid, Pharmaceutical industry, Birth control, Hospital, Mobile phone, Medical device, PDT, Nasdaq

Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will host an educational Vision Session at the Rx and Illicit Drug Summit (Rx Summit), April 18-21 in Atlanta, GA.

Key Points: 
  • Pear Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing software-based medicines called prescription digital therapeutics (PDTs), today announced the company will host an educational Vision Session at the Rx and Illicit Drug Summit (Rx Summit), April 18-21 in Atlanta, GA.
  • The Rx Summit is the largest annual gathering for global stakeholders to address the opioid and addiction epidemic and share best practices and strategies for prevention, treatment, and recovery.
  • To learn more about the Session, which will take place on Tuesday, April 19 at 8:00 ET in International Ballroom A-D, please visit www.rx-summit.com/agenda .
  • Pear Therapeutics, Inc., which is traded on Nasdaq as PEAR, is the parent company of Pear Therapeutics (US), Inc. Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs).